Suppr超能文献

Author Correction: T cell responses to SARS-CoV-2 spike cross-recognize Omicron.

作者信息

Keeton Roanne, Tincho Marius B, Ngomti Amkele, Baguma Richard, Benede Ntombi, Suzuki Akiko, Khan Khadija, Cele Sandile, Bernstein Mallory, Karim Farina, Madzorera Sharon V, Moyo-Gwete Thandeka, Mennen Mathilda, Skelem Sango, Adriaanse Marguerite, Mutithu Daniel, Aremu Olukayode, Stek Cari, du Bruyn Elsa, Van Der Mescht Mieke A, de Beer Zelda, de Villiers Talita R, Bodenstein Annie, van den Berg Gretha, Mendes Adriano, Strydom Amy, Venter Marietjie, Giandhari Jennifer, Naidoo Yeshnee, Pillay Sureshnee, Tegally Houriiyah, Grifoni Alba, Weiskopf Daniela, Sette Alessandro, Wilkinson Robert J, de Oliveira Tulio, Bekker Linda-Gail, Gray Glenda, Ueckermann Veronica, Rossouw Theresa, Boswell Michael T, Bhiman Jinal N, Moore Penny L, Sigal Alex, Ntusi Ntobeko A B, Burgers Wendy A, Riou Catherine

机构信息

Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa.

Division of Medical Virology, Department of Pathology, University of Cape Town; Observatory, Cape Town, South Africa.

出版信息

Nature. 2022 Apr;604(7907):E25. doi: 10.1038/s41586-022-04708-y.

DOI:10.1038/s41586-022-04708-y
PMID:35396582
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8993033/
Abstract
摘要

相似文献

1
Author Correction: T cell responses to SARS-CoV-2 spike cross-recognize Omicron.作者更正：针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突蛋白的T细胞反应可交叉识别奥密克戎毒株。
Nature. 2022 Apr;604(7907):E25. doi: 10.1038/s41586-022-04708-y.
2
Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain.新冠病毒奥密克戎变异株刺突蛋白胞外域的冷冻电镜结构
Nat Commun. 2022 Mar 3;13(1):1214. doi: 10.1038/s41467-022-28882-9.
3
Omicron SARS-CoV-2 Variant Spike Protein Shows an Increased Affinity to the Human ACE2 Receptor: An In Silico Analysis.奥密克戎SARS-CoV-2变体刺突蛋白对人ACE2受体的亲和力增加：一项计算机模拟分析。
Pathogens. 2021 Dec 31;11(1):45. doi: 10.3390/pathogens11010045.
4
Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.SARS-CoV-2 的奥密克戎和德尔塔变体：刺突蛋白的比较计算研究。
J Med Virol. 2022 Apr;94(4):1641-1649. doi: 10.1002/jmv.27526. Epub 2021 Dec 27.
5
SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction Residues.严重急性呼吸综合征冠状病毒2型奥密克戎变异株的突变速度比追踪速度还快：刺突蛋白/血管紧张素转换酶2相互作用残基上的多个突变
Immune Netw. 2021 Dec 23;21(6):e38. doi: 10.4110/in.2021.21.e38. eCollection 2021 Dec.
6
SARS-CoV-2 Omicron Symptomatic Infections in Previously Infected or Vaccinated South African Healthcare Workers.曾感染过或接种过疫苗的南非医护人员中的新冠病毒奥密克戎变异株有症状感染情况
Vaccines (Basel). 2022 Mar 17;10(3):459. doi: 10.3390/vaccines10030459.
7
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variant.mRNA-1273和BNT162b2信使核糖核酸疫苗对严重急性呼吸综合征冠状病毒2奥密克戎变种的中和活性有所降低。
bioRxiv. 2021 Dec 22:2021.12.20.473557. doi: 10.1101/2021.12.20.473557.
8
Omicron Variant of SARS-CoV-2 Virus: Evaluation of the Possible Impact on People Affected by Diabetes Mellitus.SARS-CoV-2 病毒奥密克戎变异株：评估其对糖尿病患者可能产生的影响。
Front Endocrinol (Lausanne). 2022 Mar 7;13:847993. doi: 10.3389/fendo.2022.847993. eCollection 2022.
9
Allosteric Determinants of the SARS-CoV-2 Spike Protein Binding with Nanobodies: Examining Mechanisms of Mutational Escape and Sensitivity of the Omicron Variant.SARS-CoV-2 刺突蛋白与纳米抗体结合的变构决定因素：研究突变逃逸机制和奥密克戎变体的敏感性。
Int J Mol Sci. 2022 Feb 16;23(4):2172. doi: 10.3390/ijms23042172.
10
[How did Omicron evolve and why does this SARS-CoV-2 variant spread so fast?].[奥密克戎是如何演变的，以及为何这种新冠病毒变种传播如此之快？]
Lakartidningen. 2022 Jan 18;119:21242.

引用本文的文献

1
mRNA vaccines against SARS-CoV-2 induce divergent antigen-specific T-cell responses in patients with lung cancer.mRNA 疫苗针对 SARS-CoV-2 可诱导肺癌患者产生不同的抗原特异性 T 细胞反应。
J Immunother Cancer. 2024 Jan 4;12(1):e007922. doi: 10.1136/jitc-2023-007922.
2
Safety and immunogenicity of a heterologous booster with an RBD virus-like particle vaccine following two- or three-dose inactivated COVID-19 vaccine.两针或三针灭活新冠病毒疫苗后使用 RBD 病毒样颗粒疫苗进行异源加强免疫的安全性和免疫原性。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2267869. doi: 10.1080/21645515.2023.2267869. Epub 2023 Oct 19.
3
Decreased breadth of the antibody response to the spike protein of SARS-CoV-2 after repeated vaccination.多次接种疫苗后，对 SARS-CoV-2 刺突蛋白的抗体反应变窄。
Front Immunol. 2023 Apr 3;14:1157263. doi: 10.3389/fimmu.2023.1157263. eCollection 2023.
4
Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months.在乌干达，快速、早期和强效的 Spike 定向 IgG、IgM 和 IgA 可将无症状和轻度症状的 COVID-19 区分开来，且 IgG 可持续 28 个月。
Front Immunol. 2023 Mar 16;14:1152522. doi: 10.3389/fimmu.2023.1152522. eCollection 2023.
5
Potency assessment of IFNγ-producing SARS-CoV-2-specific T cells from COVID-19 convalescent subjects.从 COVID-19 康复患者中评估 IFNγ 产生的 SARS-CoV-2 特异性 T 细胞的效价。
Life Sci Alliance. 2023 Mar 20;6(6). doi: 10.26508/lsa.202201759. Print 2023 Jun.
6
A fourth dose of the inactivated SARS-CoV-2 vaccine redistributes humoral immunity to the N-terminal domain.第四剂灭活 SARS-CoV-2 疫苗将体液免疫重新分配到 N 端结构域。
Nat Commun. 2022 Nov 11;13(1):6866. doi: 10.1038/s41467-022-34633-7.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验